Read More Pharma Industry News Leap Therapeutics gets FDA orphan status for DKN-01 for gastric and gastroesophageal junction cancer US immuno-oncology company Leap Therapeutics has been granted orphan drug designation for DKN-01 from the US Food and… bypharmanewsdailyJune 12, 2020